384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid...

by Yu Xia, Hui Gan, Xiaoping Jin, Amy Prawira, Jermaine Coward, Anna Mislang, Adnan Nagrial, Baiyong Li, Zhongmin Maxwell Wang, Kon Yew Kwek, Dennis Xia
Published 2020-11-01